The present study was performed to evaluate clinically the therapeutic efficacy of human anti-tetanic globulin in established cases of tetanus. The study was conducted in 100 patients in India with tetanus receiving treatment at P.B.M. Hospital, Bikaner. The human anti-tetanic globulin was given in addition to equine anti-tetanic serum, to all those patients who could afford to purchase the same, irrespective of age, sex or the severity of the disease, during the period of study. Except for the administration of human anti-tetanic globulin, the management of all the patients was identical. The study revealed that human anti-tetanic globulin is effective for patients with a short period of onset. Patients having prolonged spasms at frequent intervals were also the beneficiaries, to some extent. The hospitalization period of all the patients receiving human anti-tetanic globulin was shortened.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/BF02469011 | DOI Listing |
East Mediterr Health J
October 2014
Laboratoire Microbiologie, santé et environnement, Centre Azm pour la Recherche en Biotechnologie et ses Applications, École doctorale des Sciences et de Technologie, Université Libanaise, Tripoli (Liban); Faculté de Santé publique, section 3, Université Libanaise, Tripoli (Liban).
Tetanus is a serious illness that kills about one million people a year globally. This study aimed to i) evaluate immunity against tetanus (by antibodies titres in blood) among health staff and students at the Public Health Faculty, Lebanese University, ii) explore the determinants of the anti-tetanus immunity by a questionnaire and iii) estimate anti-tetanic serum use in the emergency departments of two hospitals (1 private, 1 public) in Tripoli. Most of the participants (76.
View Article and Find Full Text PDFPLoS One
August 2014
INSERM, UMR 1064, Nantes, France ; CHU de Nantes, ITUN, Nantes, France ; Université de Nantes, Faculté de Médecine, Nantes, France.
In order to characterize the reactivity of B cells against nominal antigens, a method based on the coupling of antigens onto the surface of fluorescent core polystyrene beads was developed. We first demonstrate that murine B cells with a human MOG-specific BCR are able to interact with MOG-coated beads and do not recognize beads coated with human albumin or pp65. B cells purified from human healthy volunteer blood or immunized individuals were tested for their ability to interact with various nominal antigens, including viral, vaccine, self and alloantigens, chosen for their usefulness in studying a variety of pathological processes.
View Article and Find Full Text PDFMed Arh
May 2012
Eye Clinic, Clinical center of University of Prishtina, Republic of Kosova.
Introduction: In the Eye Clinic during 2008-2010 we have treated 446 patients, where 252 were hospitalized patients while 184 weren't. Treated patients were 1-85 years old.
Aim Of This Study: AIM OF THIS STUDY is to present our experience in treatment of patients with eye lids injuries and their reconstruction.
Rev Neurol (Paris)
April 2005
Service d'Oto-Rhino-Laryngologie, Faculté de Médecine, Annaba, Algérie.
Introduction: Peripheral facial paralysis (PFP) is a frequent symptom, idiopathic forms predominate. Toxin-related PFP was not common pathology and apparently has not been documented in the literature.
Observation: We report a case of sudden-onset PFP which resolved rapidly in a patient given tetanic anti-serotherapy for a wound of the lower limb.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!